Cedars-Sinai Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cedars-Sinai Medical Center sits in the top decile of US sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count).
Cedars-Sinai Medical Center: 339 sponsored US clinical trials, 70 recruiting.
Cedars-Sinai Medical Center sponsors 339 registered US clinical trials on ClinicalTrials.gov, 70 of them currently recruiting, and 180 completed. 42 of these trials are in Phase 3-4 (later-stage) and 83 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bladder Cancer, with 6 trials.
Top-decile sponsor footprint
Cedars-Sinai Medical Center ranks in the top decile of sponsors by registered trial count (#106 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
180 of 230 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
339 total, page 4 of 7
The Effect of Mindfulness/Meditation on Post-operative Pain and Opioid Consumption
NCT04855968
The Effect of Cross-Education on Shoulder Arthroscopy
NCT04470570
WARRIOR Ancillary Study for CCTA Analysis
NCT05035056
Effect of Positive Attitudes on Behavior and Wellness
NCT04441632
Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19)
NCT04348500
Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL
NCT03751709
Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients
NCT04225988
SMS Education for Post-operative Pain
NCT04039191
Wingspan One Year Vascular Imaging Events and Neurologic Outcomes
NCT04221984
A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine
NCT04114058
Virtual Reality in SOD
NCT03999333
Intraoperative Fluorescence With Augmented Reality
NCT03888014
Detection of miRNAs in HPA Axis Function in Healthy Subjects
NCT04066647
A Prospective Case Series Analysis of Initial Users of the Urovac Device
NCT03872518
Effect of Evolocumab on Coronary Atherosclerosis
NCT03689946
Endoscopic Trigger Finger Release
NCT03883477
The IBD&me Randomized Controlled Trial
NCT03695783
Dynamic Web-Based Interventions to Improve Update of Preventive Health Recommendations in IBD
NCT05997537
Tissue Expansion in Breast Reconstruction Without Drains
NCT03784859
Virtual Reality After Breast Reconstruction Surgery
NCT03801616
Ultrasound Guided Peripheral IV Insertion
NCT03841864
Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears
NCT03805698
Reactive vs. Proactive Pain Control in IBD
NCT03798405
Efficacy and Safety of SYN-010 in IBS-C
NCT03763175
Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
NCT03815110
Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure
NCT03688100
Cut Your Blood Pressure 3
NCT03726710
Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery
NCT03738904
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
NCT03723447
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
NCT03219372
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance
NCT03679260
Maintenance Dosing of Vitamin D in Crohn's Disease
NCT03615378
Rifaximin on Visceral Hypersensitivity
NCT03462966
The Impact of Community Exercise on Social Connectedness and Falls in Older Adults: Leveraging Exercise to Age in Place
NCT03624049
Development and Validation of a Digital Pain-Reduction Kit for Musculoskeletal Injuries
NCT03187132
Antibiotics During Intrauterine Balloon Tamponade Placement
NCT03478163
Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy
NCT03418324
Virtual Reality in Labor and Delivery for Reduction in Pain
NCT03437031
Comparison of Two Electroencephalograms (EEG) Monitors in Patients Undergoing General Anesthesia
NCT02928172
Comparison of 3 Direct Laryngoscopes for Tracheal Intubation in Patients Undergoing Lumbar Spine Surgery
NCT02955511
Comparative Effectiveness Trial of Communication Strategies in the Management of Chronic Pain
NCT03301623
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
NCT02653833
ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy
NCT03145298
Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block
NCT02548104
High Resolution MRI Study for Prostate Cancer
NCT03292874
Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients
NCT03194321
Trial of Low Residue Diet Versus Clear Liquids Following Elective Colorectal Surgery
NCT03260426
Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function
NCT03166787
18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes
NCT03095313
Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCs
NCT02941705
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 40 |
| Phase 3 | 9 |
| Phase 4 | 33 |
What is open in the Cedars-Sinai Medical Center pipeline
70 recruiting of 339 indexed (21% open); 180 completed (53%).
Phase mix: 42 late (III/IV) vs 83 early (I/II) (early-phase heavy).
Top condition: Bladder Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cedars-Sinai Medical Center: open-pipeline peers nationwide
Peers matched on 339 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Cedars-Sinai Medical Center sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 339 trials (± recruiting share)
- National Institutes of Health Clinical Center (CC) · 338 trials · 7% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
Sponsors near 21% open enrollment (± trial volume)
- University of Colorado, Denver · 21% recruiting · 1,283 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this Cedars-Sinai Medical Center page
339 registered trials is a research-attention snapshot, not an endorsement of Cedars-Sinai Medical Center or any single study.
- 70 of Cedars-Sinai Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bladder Cancer is the condition Cedars-Sinai Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bladder Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cedars-Sinai Medical Center pipeline card: 339 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.